Gyrodyne , LLC (NASDAQ:GYRO) Sees Significant Drop in Short Interest

Posted by Defense World Staff on Feb 2nd, 2026

Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 40 shares, a drop of 14.9% from the December 31st total of 47 shares. Based on an average daily volume of 890 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 890 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Trading of Gyrodyne

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bulldog Investors LLP acquired a new position in shares of Gyrodyne during the third quarter worth about $601,000. Teton Advisors LLC purchased a new stake in Gyrodyne in the 3rd quarter valued at approximately $177,000. Susquehanna International Group LLP acquired a new position in Gyrodyne during the 3rd quarter worth approximately $142,000. Finally, Advisory Services Network LLC acquired a new position in Gyrodyne during the 3rd quarter worth approximately $77,000. Hedge funds and other institutional investors own 71.36% of the company’s stock.

Gyrodyne Stock Performance

Gyrodyne stock opened at $8.75 on Monday. The business has a 50 day simple moving average of $9.16 and a 200-day simple moving average of $9.66. Gyrodyne has a 12 month low of $6.80 and a 12 month high of $12.00.

About Gyrodyne

(Get Free Report)

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.